Status:

COMPLETED

Validation of Biomarkers of Exposure and Host Response

Lead Sponsor:

University of Nebraska

Collaborating Sponsors:

Institute for Science and Health

Conditions:

Cigarette Smoker

Eligibility:

All Genders

19+ years

Phase:

NA

Brief Summary

This study will evaluate biomarkers measured in exhaled breath condensate (EBC) to assess clinical strategies of harm reduction. It will take advantage of a recently developed device that permits coll...

Detailed Description

The proposed study will evaluate biomarkers measured in exhaled breath condensate (EBC) for the purpose of assessing clinical strategies of harm reduction. It will take advantage of a recently develop...

Eligibility Criteria

Inclusion

  • Subjects must be 19 years of age or older
  • Have a stable smoking habit greater than three months
  • Have smoked for at least 5 pack years
  • Be willing to make a serious quit attempt and be willing to use nicotine replacement therapy
  • Be able to give informed consent

Exclusion

  • regular use of anti-inflammatory medication; presence of any inflammatory \*disease of the respiratory tract including moderate or worse COPD (FEV1 \< 80% predicted and FEV1/FVC ratio \< 0.7) or PFT criteria for asthma (improvement in FEV1\>12% of predicted and \>200ml).
  • Subjects with normal lung function who meet criteria for diagnosis of chronic bronchitis will be excluded.
  • Subjects with stable medical conditions, excluding inflammatory lung disease, will be permitted to participate, providing anti-inflammatory therapies are not used regularly and providing there has been no change in their clinical status in the two months prior to beginning the study.

Key Trial Info

Start Date :

December 1 2005

Trial Type :

INTERVENTIONAL

End Date :

September 1 2007

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00468234

Start Date

December 1 2005

End Date

September 1 2007

Last Update

August 31 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Nebraska Medical Center

Omaha, Nebraska, United States, 68198